IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10

In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury.

Source: Frontiers in Immunology - January 27, 2020 Category: Allergy & Immunology Source Type: research